Filter Results:
(504)
Show Results For
- All HBS Web
(1,718)
- Faculty Publications (504)
Show Results For
- All HBS Web
(1,718)
- Faculty Publications (504)
- March 2024 (Revised January 2025)
- Case
Hippo: Weathering the Storm of the Home Insurance Crisis
By: Lauren Cohen, Grace Headinger and Sophia Pan
Rick McCathron, CEO of Hippo, considered how the firm’s underwriting model could account for the effects of climate change. Along with providing smart home packages, targeting risk-friendly customers, and using data-driven pricing, the Insurtech used technologically... View Details
Keywords: Fintech; Underwriters; Big Data; Insurance Companies; Business Model Design; Weather Insurance; Business Model; Forecasting and Prediction; Climate Change; Environmental Sustainability; Green Technology; Technological Innovation; Natural Environment; Natural Disasters; Weather; Business Strategy; Competitive Advantage; Business Earnings; Insurance; Social Issues; Insurance Industry; United States; California
- March 2024
- Case
Nomad: A License to Bank
By: Paul A. Gompers and Pedro Levindo
In late 2023, Lucas Vargas, CEO and co-founder of Nomad, a fintech that offered financial services in the United States for Brazilian residents, had to decide what to do to ensure the company’s continued expansion. Nomad launched its first product, a U.S. digital bank... View Details
Keywords: Mergers and Acquisitions; Business Startups; Customer Satisfaction; Decision Making; Entrepreneurship; Banks and Banking; Initial Public Offering; Global Strategy; Growth and Development Strategy; Brands and Branding; Marketing Strategy; Product Launch; Organizational Culture; Going Public; Ownership Stake; Innovation and Invention; Strategic Planning; Business and Government Relations; Business and Stakeholder Relations; Risk and Uncertainty; Business Strategy; Competitive Advantage; Corporate Strategy; Diversification; Expansion; Vertical Integration; Leadership; Law; Banking Industry; Technology Industry; Service Industry; Brazil; United States; North America; Latin America
- February 2024
- Article
Investing in Long-Term Health
By: Katherine Baicker and Amitabh Chandra
Baicker, Katherine, and Amitabh Chandra. "Investing in Long-Term Health." e240193. JAMA Health Forum 5, no. 2 (February 2024).
- 2023
- Working Paper
When Insurers Exit: Climate Losses, Fragile Insurers, and Mortgage Markets
By: Pari Sastry, Ishita Sen and Ana-Maria Tenekedjieva
This paper studies how homeowners insurance markets respond to growing climate losses and how this impacts mortgage market dynamics. Using Florida as a case study, we show that traditional insurers are exiting high risk areas, and new lower quality insurers are... View Details
Keywords: Insurance; Natural Disasters; Governing Rules, Regulations, and Reforms; Insurance Industry; Florida
Sastry, Pari, Ishita Sen, and Ana-Maria Tenekedjieva. "When Insurers Exit: Climate Losses, Fragile Insurers, and Mortgage Markets." Harvard Business School Working Paper, No. 24-051, February 2024. (SSRN Working Paper Series, No. 4674279, December 2023.)
- January 2024
- Case
Net Zero Insurance Alliance: An Alliance in Crisis
By: Peter Tufano and Karina Val
The Net Zero Insurance Alliance (NZIA), a UN-convened alliance of major global insurers, was formed in 2021, but by 2023 had lost over 60% of its members. While NZIA had enjoyed a rapid and productive start by setting standards for the industry and sharing best... View Details
- January 2024
- Article
Cost of Exempting Sole Orphan Drugs from Medicare Negotiation
By: Matthew Vogel, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim and Benjamin N. Rome
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved solely for the treatment of a single rare disease.
Objective: To estimate Medicare spending and global... View Details
Objective: To estimate Medicare spending and global... View Details
Vogel, Matthew, Olivia Zhao, William B. Feldman, Amitabh Chandra, Aaron S. Kesselheim, and Benjamin N. Rome. "Cost of Exempting Sole Orphan Drugs from Medicare Negotiation." JAMA Internal Medicine 184, no. 1 (January 2024): 63–69.
- December 12, 2023
- Article
Prices for Common Services at Quaternary vs Nonquaternary Hospitals
By: Brandon W. Yan, Maximilian J. Pany and Leemore S. Dafny
Using commercial health insurance claims data from 2017-2019, we assessed whether quaternary hospitals charged higher prices for common, unspecialized services also offered by nonquaternary hospitals. We found quaternary-hospital price premiums of 8.2 percent, on... View Details
Yan, Brandon W., Maximilian J. Pany, and Leemore S. Dafny. "Prices for Common Services at Quaternary vs Nonquaternary Hospitals." JAMA, the Journal of the American Medical Association 330, no. 22 (December 12, 2023): 2211–2213.
- November 2023 (Revised July 2024)
- Case
Aviva plc: Examining Net Zero
The board of Aviva Plc, one of the world’s largest insurers, must review its climate risk exposures and evaluate next steps. Risk experts at the firm have conducted a robust set of analyses prepared for its regulator, the Bank of England, simulating how various climate... View Details
Keywords: Analysis; Climate Change; Insurance; Governing and Advisory Boards; Risk Management; Adaptation; Insurance Industry; Insurance Industry; Europe; United Kingdom
Tufano, Peter, Brian Trelstad, and Matteo Gasparini. "Aviva plc: Examining Net Zero." Harvard Business School Case 324-008, November 2023. (Revised July 2024.)
- 2023
- Government Testimony
Congressional Statement for the Record, Hearing on Factors Influencing the High Cost of Insurance for Consumers
By: Ishita Sen
Sen, Ishita. "Congressional Statement for the Record, Hearing on Factors Influencing the High Cost of Insurance for Consumers." Government Testimony, U.S. House of Representatives, Committee on Financial Services, Subcommittee on Housing and Insurance, November 2023.
- September 2023 (Revised October 2024)
- Case
Forecasting Climate Risks: Aviva’s Climate Calculus
By: Mark Egan and Peter Tufano
In late 2021, Ben Carr, Director of Analytics and Capital Modeling at Aviva Plc (Aviva)—a leading insurer with core operations in the UK, Ireland and Canada,—was preparing for an upcoming presentation before the company's board which included its CEO, Amanda Blanc,... View Details
Keywords: Climate Risk; Climate Finance; Forecasting; Insurance; Risk Measurement; Climate Change; Risk Management; Forecasting and Prediction; Insurance Industry; United States
Egan, Mark, and Peter Tufano. "Forecasting Climate Risks: Aviva’s Climate Calculus." Harvard Business School Case 224-025, September 2023. (Revised October 2024.)
- September 2023
- Case
Healthy.io: The Negotiation for the Medical Selfie
By: Amit Goldenberg and Kumba Sennaar
Healthy.io, an Israeli digital health company, prepares to enter the U.S. market with its chronic kidney disease test. A product safety approval is delayed, putting the company’s cash runway at risk. How should the CEO negotiate his offer to insurance companies ahead... View Details
Keywords: Negotiation; Entrepreneurship; Venture Capital; Operations; Business Startups; Market Entry and Exit; Health Industry; Israel; United Kingdom; United States
Goldenberg, Amit, and Kumba Sennaar. "Healthy.io: The Negotiation for the Medical Selfie." Harvard Business School Case 924-001, September 2023.
- August 2023
- Supplement
Zurich Insurance (A)
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Feser, Karolin Frankenberger and Ana Procopio Schoen
- August 2023
- Supplement
Zurich Insurance (B)
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Freser, Karolin Frankenberger and Ana Procopio Schoen
- August 2023
- Supplement
Zurich Insurance (C): Re-Establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Freser, Karolin Frankenberger and Ana Procopio Schoen
Casadesus-Masanell, Ramon, Stefano Brusoni, Claudio Freser, Karolin Frankenberger, and Ana Procopio Schoen. "Zurich Insurance (C): Re-Establishing a Leading Market Position in Retail." Harvard Business School Supplement 724-366, August 2023.
- August 2023
- Supplement
Zurich Insurance (B): Re-Establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Freser, Karolin Frankenberger and Ana Procopio Schoen
Casadesus-Masanell, Ramon, Stefano Brusoni, Claudio Freser, Karolin Frankenberger, and Ana Procopio Schoen. "Zurich Insurance (B): Re-Establishing a Leading Market Position in Retail." Harvard Business School Supplement 724-365, August 2023.
- July 2023 (Revised April 2024)
- Case
Zurich Insurance (A): Re-establishing a Leading Market Position in Retail
By: Ramon Casadesus-Masanell, Stefano Brusoni, Claudio Feser, Karolin Frankenberger and Ana Procopio Schoen
Casadesus-Masanell, Ramon, Stefano Brusoni, Claudio Feser, Karolin Frankenberger, and Ana Procopio Schoen. "Zurich Insurance (A): Re-establishing a Leading Market Position in Retail." Harvard Business School Case 724-362, July 2023. (Revised April 2024.)
- July 2023
- Case
DayTwo: Going to Market with Gut Microbiome (Abridged)
By: Ayelet Israeli
DayTwo is a young Israeli startup that applies research on the gut microbiome and machine learning algorithms to deliver personalized nutritional recommendations to its users in order to minimize blood sugar spikes after meals. After a first year of trial rollout in... View Details
Keywords: Business Startups; AI and Machine Learning; Nutrition; Market Entry and Exit; Product Marketing; Distribution Channels
Israeli, Ayelet. "DayTwo: Going to Market with Gut Microbiome (Abridged)." Harvard Business School Case 524-015, July 2023.
- Summer 2023
- Article
Do Policies to Increase Access to Treatment for Opioid Use Disorder Work?
By: Eric Barrette, Leemore S. Dafny and Karen Shen
Even among commercially insured individuals, opioid use disorder is undertreated in the United States: nearly half receive no treatment within six months of a new diagnosis. Using a difference-in-differences specification exploiting the extension of insurance parity... View Details
Keywords: Opioid Treatment; Medication-assisted Treatment; Substance Use Disorder; Private Insurance; Insurance; Health Care and Treatment
Barrette, Eric, Leemore S. Dafny, and Karen Shen. "Do Policies to Increase Access to Treatment for Opioid Use Disorder Work?" American Journal of Health Economics 9, no. 3 (Summer 2023): 297–330.
- 2023
- Working Paper
The Market for Sharing Interest Rate Risk: Quantities and Asset Prices
By: Umang Khetan, Jane Li, Ioana Neamtu and Ishita Sen
We study the extent of interest rate risk sharing across the financial system using granular positions and transactions data in interest rate swaps. We show that pension and insurance (PF&I) sector emerges as a natural counterparty to banks and corporations: overall,... View Details
Keywords: Interest Rates; Investment Funds; Banks and Banking; Insurance; Investment Banking; Risk and Uncertainty
Khetan, Umang, Jane Li, Ioana Neamtu, and Ishita Sen. "The Market for Sharing Interest Rate Risk: Quantities and Asset Prices." Harvard Business School Working Paper, No. 24-052, February 2024.
- 3 Jun 2023
- Talk
Health Care Innovation Opportunities Created by COVID-19 and How to Make Them Happen
The crush of patients created by COVID enabled the creation of sites for care outside the traditional hospital, such as retail pharmacies, ambulatory surgery centers, urgent care centers, telemedicine, and wireless sensors. Public policy mirrored these changes by... View Details
Keywords: Policy; Health Pandemics; Health Care and Treatment; Innovation and Invention; Insurance Industry; Insurance Industry
Herzlinger, Regina E. "Health Care Innovation Opportunities Created by COVID-19 and How to Make Them Happen." Harvard Business School Alumni Reunion, Boston, MA, June 3, 2023. (Link to cases described in this talk.)